Noor Jehanzeb 4
4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Zimmer Biomet (ZBH) SVP Noor Jehanzeb Receives RSU Award
What Happened Noor Jehanzeb, Senior Vice President and Chief Strategy, Innovation & Business Development Officer at Zimmer Biomet (ZBH), was granted 1,857 restricted stock units (RSUs) on 2026-06-01. The Form 4 shows an acquisition price of $0 (this is an equity award, not a cash purchase). The RSUs are a derivative award that can convert into one share of common stock per unit upon vesting.
Key Details
- Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (filed within the normal reporting window).
- Grant: 1,857 RSUs; reported acquisition price: $0 (award/derivative).
- Vesting: vests annually over three years in one-third increments, commencing June 1, 2027 (per filing footnote).
- Shares owned after transaction: not specified in the provided filing summary.
- Footnotes: F1 — each RSU equals a contingent right to one share; F2 — three-year annual vesting schedule.
- No indication of a sale, exercise, or tax-withholding disposition in this filing.
Context RSU grants are a form of equity compensation; they do not involve an immediate cash purchase or sale and only convert into actual shares if and when they vest. This filing reflects a routine compensation award to an executive rather than an open-market buy or sale.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-06-01+1,857→ 1,857 total→ Common Stock (1,857 underlying)
Footnotes (2)
- [F1]Each RSU represents a contingent right to receive one share of Company common stock.
- [F2]Vests annually over three years in increments of one-third each year, commencing June 1, 2027.